R 2579 R 2579 (Diltiazem CD 300 mg)

Pill imprint R 2579 R 2579 has been identified as Diltiazem hydrochloride extended-release (CD) 300 mg.

Diltiazem is used in the treatment of atrial fibrillation; high blood pressure; atrial flutter; supraventricular tachycardia; raynaud's syndrome (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for R 2579 R 2579

Diltiazem hydrochloride extended-release (CD) 300 mg R 2579 R 2579
Diltiazem hydrochloride extended-release (CD) 300 mg R 2579 R 2579 Front
Diltiazem hydrochloride extended-release (CD) 300 mg R 2579 R 2579 Back
Diltiazem hydrochloride extended-release (CD)
Imprint:
R 2579
R 2579
Strength:
300 mg
Color:
Green / Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcium channel blocking agents
Group IV antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Actavis
National Drug Code (NDC):
00228-2579
Inactive Ingredients:
methacrylic acid - methyl methacrylate copolymer (1:1)
methacrylic acid - methyl methacrylate copolymer (1:2)
ammonia
gelatin
hydroxypropyl cellulose
propylene glycol
silicon dioxide
sodium lauryl sulfate
sucrose
corn starch
magnesium silicate
titanium dioxide
triethyl citrate
D&C Yellow No. 10
FD&C Green No. 3
ferrosoferric oxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0977 Amerisource Health Services
63739-0286 McKesson Packaging Services
54868-4992 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)